Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension Cyril H. Barton, Zhemin Ni, Nosratola D. Vaziri Kidney International Volume 60, Issue 3, Pages 1083-1087 (September 2001) DOI: 10.1046/j.1523-1755.2001.0600031083.x Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 1 Representative Western blot and group data depicting thoracic aorta nitrotyrosine abundance in the sham-operated normal control and abdominal aorta-banded (AAB) groups.N = 6 in each group. *P < 0.01. Kidney International 2001 60, 1083-1087DOI: (10.1046/j.1523-1755.2001.0600031083.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 2 Representative Western blot and group data depicting abdominal aorta nitrotyrosine abundance in the sham-operated normal control and abdominal aorta-banded (AAB) groups.N = 6 in each group. Kidney International 2001 60, 1083-1087DOI: (10.1046/j.1523-1755.2001.0600031083.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 3 Representative Western blot and group data depicting brain nitrotyrosine abundance in the sham-operated normal control and abdominal aorta-banded (AAB) groups.N = 6 in each group. *P < 0.01. Kidney International 2001 60, 1083-1087DOI: (10.1046/j.1523-1755.2001.0600031083.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 4 Representative Western blot and group data depicting heart nitrotyrosine abundance in the sham-operated normal control and abdominal aorta-banded (AAB) groups.N = 6 in each group. *P < 0.01. Kidney International 2001 60, 1083-1087DOI: (10.1046/j.1523-1755.2001.0600031083.x) Copyright © 2001 International Society of Nephrology Terms and Conditions